Literature DB >> 9559800

Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR.

V Speldooren1, B Heym, R Labia, M H Nicolas-Chanoine.   

Abstract

Plasmid-mediated mechanisms, comprising TEM hyperproduction, TEM derivative production, and OXA production, lead to amoxicillin-clavulanic acid resistance in enterobacteria. The ability of the single-strand conformation polymorphism (SSCP)-PCR method to differentiate the genes encoding inhibitor-resistant beta-lactamases was evaluated with three bla(TEM) primer pairs. The bla(TEM) genes, which were known to be different on the basis of their nucleotide sequences (bla[TEM-1A], bla[TEM-1B], bla[TEM-2], bla[TEM-30], bla[TEM-32], and bla[TEM-35]), were identified as different by their electrophoretic mobilities. The bla(TEM-33), bla(TEM-34), bla(TEM-36), bla(TEM-37), bla(TEM-38), and bla(TEM-39) genes, whose sequence differences have been established by oligotyping, displayed different SSCP profiles for different fragments, suggesting genetic differences in addition to those defined by oligotyping. Confirmed by sequencing, these additional genetic events concerned silent mutations at certain positions and, notably, a G-->T transversion at position 1 of the -10 consensus sequence in bla(TEM-34), bla(TEM-36), bla(TEM-37), and bla(TEM-39). Applied to eight clinical isolates of Escherichia coli resistant to amoxicillin-clavulanic acid, the SSCP method detected TEM-1 in three strains and TEM-30, TEM-32, and TEM-35 in three other strains, respectively. A novel TEM derivative (TEM-58) was detected in another strain, and the deduced amino acid sequence showed two substitutions: Arg244Ser, which is known to confer amoxicillin-clavulanic acid resistance in TEM-30, and Val261Ile, which has not been described previously. The eighth strain produced an OXA beta-lactamase. Given the discriminatory power and the applicability of SSCP-PCR, this method can be proposed as a means of following the evolution of the frequencies of the different inhibitor-resistant beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559800      PMCID: PMC105559          DOI: 10.1128/AAC.42.4.879

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli.

Authors:  J L Martinez; M F Vicente; A Delgado-Iribarren; J C Perez-Diaz; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

2.  Reduced susceptibility to co-amoxiclav in Escherichia coli, Salmonella typhimurium and Klebsiella pneumoniae isolated in Romania between 1985 and 1993.

Authors:  F Espinasse; R Gheorghiu; A Poiata; R Labia; M H Nicolas-Chanoine
Journal:  J Antimicrob Chemother       Date:  1997-01       Impact factor: 5.790

3.  Molecular diversity and evolution of blaTEM genes encoding beta-lactamases resistant to clavulanic acid in clinical E. coli.

Authors:  M M Caniça; C Y Lu; R Krishnamoorthy; G C Paul
Journal:  J Mol Evol       Date:  1997-01       Impact factor: 2.395

4.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 5.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  Effects of plasmid copy number and runaway plasmid replication on overproduction and excretion of beta-lactamase from Escherichia coli.

Authors:  A P Togna; M L Shuler; D B Wilson
Journal:  Biotechnol Prog       Date:  1993 Jan-Feb

7.  Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.

Authors:  P Stapleton; P J Wu; A King; K Shannon; G French; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

8.  Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.

Authors:  G V Doern; A B Brueggemann; G Pierce; H P Holley; A Rauch
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

9.  Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli serotype O15.

Authors:  K Shannon; H Williams; A King; I Phillips
Journal:  FEMS Microbiol Lett       Date:  1990-02       Impact factor: 2.742

10.  Convergent evolution of TEM-26, a beta-lactamase with extended-spectrum activity.

Authors:  L C Hibbert-Rogers; J Heritage; N Todd; P M Hawkey
Journal:  J Antimicrob Chemother       Date:  1994-04       Impact factor: 5.790

View more
  28 in total

1.  Updated sequence information and proposed nomenclature for bla(TEM) genes and their promoters.

Authors:  V Leflon-Guibout; B Heym; M Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  Inhibitor-resistant TEM-33 beta-lactamase in a Shigella sonnei isolate.

Authors:  D Sirot; C Chanal; R Bonnet; C De Champs; L Bret
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  First description of a TEM-30 (IRT-2)-producing Klebsiella oxytoca isolate.

Authors:  Sophie A Granier; Jean-Claude Nguyen Van; Marie-Dominique Kitzis; Fred W Goldstein; Véronique Leflon-Guibout; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 4.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

5.  Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases.

Authors:  C C Randegger; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

6.  TEM-103/IRT-28 beta-lactamase, a new TEM variant produced by Escherichia coli BM4511.

Authors:  Rodrigo Alonso; Guy Gerbaud; Marc Galimand; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  Using nucleic acid microarrays to perform molecular epidemiology and detect novel β-lactamases: a snapshot of extended-spectrum β-lactamases throughout the world.

Authors:  Christine Lascols; Meredith Hackel; Andrea M Hujer; Steven H Marshall; Sam K Bouchillon; Daryl J Hoban; Stephen P Hawser; Robert E Badal; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2012-02-08       Impact factor: 5.948

8.  Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients.

Authors:  Salomon Ohana; Veronique Leflon; Esthel Ronco; Martin Rottman; Didier Guillemot; Sylvie Lortat-Jacob; Pierre Denys; Georges Loubert; Marie-Helène Nicolas-Chanoine; Jean-Louis Gaillard; Christine Lawrence
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

9.  Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada.

Authors:  David A Boyd; Shaun Tyler; Sara Christianson; Allison McGeer; Matthew P Muller; Barbara M Willey; Elizabeth Bryce; Michael Gardam; Patrice Nordmann; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital.

Authors:  Véronique Leflon-Guibout; Cécile Jurand; Stéphane Bonacorsi; Florence Espinasse; Marie Claude Guelfi; Françoise Duportail; Beate Heym; Edouard Bingen; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.